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Experimental  evidence  presented  in  Paper  III*  indicates  that 
removal and destruction of both rabbit virulent and avirulent strains 
of Pneumococcus Type III in the normal animal are brought about by 
the same means, namely, the phagocytic cells of the body, provided 
the integrity of the capsule becomes impaired.  It leaves unanswered, 
however, the interesting q~aestion as to whether this phagocytosis is 
"spontaneous,"  that is,  taking place without the intervention o£ a 
serum component, or whether the adjuvant action of an antibody is 
essential to  the process.  The following experiments although they 
fail to give a complete answer do nevertheless reveal the participation 
of an antibody reacting with the somatic C  carbohydrate of Tillett, 
Goebel and Avery (1)  which not only appears to play a  r61e in the 
phagocytosis of normal animals but is probably responsible for bringing 
about the non-type specific immunity which Tillett  (2)obtained in 
rabbits  vaccinated with R  pneumococcus or  the  smooth  form of a 
heterologous type. 
Methods and Materials 
The strains of Pneumoeoceus Type III and the R variants derived from them 
were the same as those mentioned in Paper I.  ~ 
• At the time this work was done, Dr. Wu held a Travelling Fellowship from 
the Peiping Union Medical School, and Dr.  Shaffer a  Fellowship in the Medical 
Sciences from the National Research Council. 
1Enders, J. F., Shatter, M. F., and Wu, C.-J., J. Exp. Med., 1936, 64, 306. 
Enders, J. F., and Shaffer, M. F., J. Exp.  Med., 1936, 64,, 7. 
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The C carbohydrate of the pneumococcus was prepared according to the pro- 
cedure of Tillett, Goebel and Avery from an R variant obtained from our stock 
strain of Pneumococcus  Type I. 
The soluble specific  substance was prepared from cultures of strain CH accord- 
ing to the procedure of Heidelberger, Goebel and Avery (3). 
Anti-R pneumococcus  serum was produced in rabbits according to the method 
described in Paper I. 
References to the techniques used in the phagocytic work have been noted in 
Papers II  8 and III. 
Effect of C Carbohydrate on the Phagocytosis of Pneumococcus Type HI 
by Normal Cells and Serum 
The antiphagocytic effect of the type specific carbohydrate in sys- 
tems containing the homologous antibody has been demonstrated by 
such  studies as  those  of Sia  (4)  and  Ward  and  Enders  (5).  This 
antibody, however, appears to be entirely absent in the normal rabbit 
as indicated by the work of Tillett (6), and the observations recorded 
below concerning the effect of the type specific carbohydrate on the 
phagocytosis of Type III pneumococcus in the rabbit system.  We 
were  induced,  therefore,  to  make  a  further  study of  the  antibody 
reacting with another known antigenic constituent of this organism, 
namely,  the  C  carbohydrate  or  species  specific  polysaccharide  of 
Tillett, Goebel and Avery.  Particular attention was directed to this 
fraction and its antibody, since the failure of Tillett to produce any 
evidence  of  increased  resistance  after  injection  of  pneumococcus 
nucleoprotein would seem to eliminate the homologous antibody from 
any participation in the natural immunity of the rabbit or that which 
ensues when intact R  forms or heterologous S  strains are employed 
as vaccines. 
In Table I, the effect  of adding 1 drop of the C carbohydrate on the phagocyto- 
sis of old cultures of strain SV in 0.25 cc. of a suspension of the leucocytes and 
serum of a normal rabbit is shown.  The number of organisms from a 22 hour 
culture taken up by the cells in the absence of C is reduced about 33 per cent when 
this substance in a dilution of 1:200 is added.  A concentration of l:l,000ex- 
hibits no depressive action on them, but does influence  the ingestion  of the 30 hour 
cultures.  In another experiment, when a culture much younger  than these (I0 
hour SV and CH) was used, the effect of the addition of the C carbohydrate was 
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even  more pronounced.  The introduction of the type specific carbohydrate does 
not  reduce  the  phagocytosis compared  with  the  control of normal serum  only. 
In the lower half of the table are included figures obtained from an experiment in 
which the C carbohydrate was added to normal human defibrinated blood.  Here, 
its effect is very pronounced  when the strain used is SV.  With  CH, its action 
though definite is less marked.  In other experiments of the same kind,  smaller 
TABLE  I 
Effect  of C  Carbohydrate on the  Phagocytosls of Pneumococcus Type III  by the 
Normal Serum and Polymorphonuclear Leucocytes of Man and the Rabbit 
Average  Ceils 
Strain  cAu  ff  Material tested  cocciN°"  Ofer  containing  No. cells counted 
~¢  10 ¢e~I$  COCCI 
per cent 
SV  --  11.2  29.0  300 
SV  C  1 : 200  7.5  24.2  264 
SV  C 1:1,000  13.3  40.0  200 
SV  SSS III 1:I,000  12.3  33.0  200 
SV  --  15.4  43.0  210 
Normal  rabbit 
SV  C 1:200  10.0  33.0  200 
cells  and  SV  C 1:1,000  10,8  27,0  150 
SV  SSS III 1:1,000  14.9  40.0  200  serum 
*SV  --  18.4  32.4  250 
SV  C 1:200  5.4  11,6  500 
*CH  --  .37.1  50.8  250 
CH  C 1:200  17.1  32.4  250 
/ t  51 
SV  18  --  61.0  94.0 
SV  18  C 1:100  0.2  2.0  50  Normal  humar 
SV  18  aSS III 1: lOO  0.0  0.0  50 
CH  18  --  221.6  100.0  50  cells  and 
CH  18  C 1:100  141.2  94.0  50  serum 
CH  18  SSS III 1:100  32.2  58.0  5 
* The data on the 10 hour cultures of CH and SV were obtained in another ex- 
periment, employing the cells and serum of a different rabbit. 
quantities of the material have been employed.  These depress the phagocytosis 
of strain SV of this age in dilutions as high as I : I0,000 to ! : IO0,O00.  Little or no 
reduction  in  the  numbers  of  strain  CH  ingested  was  brought  about  by  these 
quantities.  It is evident from the data  that the type specific carbohydrate also 
has  a  similar  action,  reducing  the numbers  of strain  SV  ingested  to  zero  and 
those of strain CH about seven times.  To us this appears to denote that in the 
particular human blood used, both type specific and anti-C antibody were present. 428  IMMUNITY  TO  PNEIYMOCOCCUS  T~/PIB IlL  IV 
To opsonize this 18 hour culture of SV with its greater quantity of capsular  ma- 
terial, the combined concentrations of both antibodies were necessary.  The avail- 
able amount of either one was by itself insufficient to bring this about.  Since in 
the CH organism of this age the loss of capsular  constituents is relatively much 
greater, opsonization  may be accomplished  by the  concentration of the single 
antibody which remains  after the elimination  of the other by addition of its ho- 
mologous antigen.  Indeed, from information derived from unrecorded experi- 
ments it is probable that certain CH cocci have become at this stage of cultivation 
so susceptible to the attack of phagocytes that they can be ingested in the absence 
of sensitization  by either the anti-SSS III or anti-C, or anti-P antibodies,  since 
the addition of all these fractions together fails to remove entirely the phagocytic 
capacity of the system.  Such organisms behave like the R variant, for we have 
found that the addition of these three known antigens  of the pneumococcus has 
practically no effect on the phagocytosis  of R  forms by the cells and serum of 
normal rabbits.  These facts we consider may also serve to explain the residual 
phagocytosis  seen after addition of the  C  carbohydrate to  the  rabbit  system 
containing  22 hour cultures of strain SV.  It is entirely possible that the cocci 
found within cells under these conditions represent forms so far degraded in respect 
to the antigenic properties of the surface that the anti-C antibody is not necessary 
for their opsonization.  To eliminate the possibility  that  the  action of the  C 
carbohydrate consisted in fixation of complement, rather than in union with and 
neutralization of an opsonin of the serum, the titre of hemolytic complement in the 
system was determined.  No diminution of complement ensued upon the addition 
of the C substance in the quantities employed. 
On the basis of these results, it can be stated that an antibody or 
antibody-like principle in the normal sera of rabbit and man reacting 
with the C  carbohydrate of the pneumococcus has a  share in the op- 
sonization  of both  rabbit  virulent  and  avirulent  smooth  strains  of 
Pneumococcus  III,  provided  the  capsule  has  become impaired,  for 
it will be recalled from the data presented in Papers II and III that 
when young and fully capsulated, both these organisms are completely 
resistant to phagocytosis in human and rabbit systems. 
The Opsonic Property of Anti-R Pneumococcus Serum 
The  fact  that  an  antibody  reacting  with  the  C  carbohydrate in 
normal serum contributed to the opsonization of the pneumoeoccus, 
together with the demonstration by Tillett of active and passive im- 
munity in rabbits following injection of R  vaccine or anti-R blood or 
serum, led us to determine whether or not a serum prepared in rabbits J'.  F.  ENDERS,  C.-~.  WU,  AND  M.  F.  SHAFFER  429 
following prolonged  treatment  with  heat-killed  R  pneumococci  could 
increase  the  phagocytosis  of  strains  CH  and  SV. 
The  usual  technique  was  modified in  the  instances  where  the  R  serum  was 
tested  by  mixing equal volumes of  this  serum  and  fresh  normal  rabbit  serum. 
This mixture was added  to the exudative leucocytes and the red ceils which had 
been  previously removed from  the  normal  serum.  In  this  way  the  antiserum 
TABLE  II 
The Opsonic Effect of Anti-R Pneumococcus Serum on the Phagocytosis of 
Pneumococcus Type HI by Rabbit Leucocytes 






















Constituents of the system 
Normal serum 
Normal serum  q-  anti-R serum 
Normal serum  -}- anti-R serum 
q- C 1:1,000 
Normal serum 
Normal serum  -k  anti-R serum 
Normal serum  -b  anti-R serum 
-[- C  1:1,000 
Normal serum 
Normal serum  -]-  anti-R serum 
Normal serum  ~  anti-R serum 
-b C  1:1,000 
Normal serum 
Normal serum  -}- anti-R serum 
Normal serum  ~  anti-R serum 
-b C  1:1,000 
Normal serum 
Normal serum  -b  anti-R serum 
Normal serum  -I- anti-R serum 


















could  be  obtained  in  sufficient  concentration  to  be  effective.  From  the  data 
assembled in Table II, it will be seen that  in  the presence of anti-R serum the 
phagocytosis of a 6 hour culture of CH is increased 100 per cent, that of a  16 hour 
culture about 47 per cent.  The number of 16 hour SV organisms ingested is also 
increased by 100 per cent.  Addition of 1 drop of 1 : 1,000 dilution of the C carbo.. 
hydrate to the mixtures containing the R  serum reduces the number of organisms 
phagocyted to a figure which is less than that of the normal serum.  The reduction 430  IMMUNITY TO  PNEUMOCOCCUS TYPE III.  IV 
is particularly marked in the case of the 6 hour CH culture.  Here, as with strain 
SV in the normal human serum, the greater effect of this substance on the younger 
cultures may, in part, depend upon the amount of surface antigen in relation to the 
quantity of available antibody.  In the older culture, antigen is reduced and the 
small amount of antibody which may remain unbound after introduction  of the C 
carbohydrate may be still sufficient for sensitization  of a considerable number of 
organisms.  Moreover, in older cultures, completely degraded forms not requiring 
the  C  antibody for opsonization  have doubtless  developed.  Had greater  con- 
centrations  of  C  carbohydrate been  employed  in  this  experiment,  the  results 
might have been even more striking. 
To obtain information  concerning the influence of the anti-R serum on R forms 
of these strains the same type of experiment was done using 6 hour cultures of the 
R variants derived from each.  It is evident  that the serum has no effect on the 
phagocytosis of that obtained from strain  CH.  There is possibly some enhance- 
ment of the phagocytosis of strain SV-R, but because of the extremely large num- 
ber of intracellular  organisms present  in all cases, and the small number of cells 
counted, no conclusive evidence is afforded of any definite action on the R organ- 
isms of this antibody.  It is certain  that extensive ingestion of these forms may 
occur in its absence. 
Taken as a  whole, these experiments indicate that the anti-C anti- 
body present in the serum of rabbits immunized with R  vaccine can 
increase the phagocytosis of the rabbit virulent and avirulent pneumo- 
cocci, provided these be obtained from cultures in which the capsules 
of the organisms are no longer intact. 
The Protective Action in Mice of Anti-R Pneumococcus  Rabbit Serum 
The previous experiments,  since they revealed a  certain amount of 
opsonic  activity  attributable  to  the  anti-C  carbohydrate  antibody, 
induced us to ascertain whether or not this entity could in the animal 
body act in the capacity of a  protective agent. 
To this end a series of mice were injected intraperitoneally  with 0.5 cc. of anti-R 
pneumococcus  rabbit  serum  prepared  by repeated  injections  of  heat-killed  R 
pneumococci, derived from a strain of Pneumococcus Type I, as noted in the section 
on technique.  A second series of animals was given the same quantity of the same 
anti-R serum,  from which the precipitin  reacting  with  the C carbohydrate had 
been removed by repeated precipitations  at the point at which maximum floccu- 
lation  occurred.  The original serum gave a positive  ring test with a dilution  of 
1:10,000 of the carbohydrate.  After absorption of precipitin,  no reaction was 
obtained using  this  technique  with dilutions  of the carbohydrate ranging  from 
1:100  to 1:100,000~  A third series of animals  was injected  with  0.5 cc. of the J.  F.  ENDERS,  C.-J.  WU,  AND  M.  1  ~.  SHAFFER  431 
anti-R serum,  which had been previonsly treated with fresh guinea pig kidney 
with the object of removing the Forssman antibody which has  been  shown  by 
Powe11 and coworkers  (7),  to increase in rabbits the therapeutic action of type 
specific pneumococcus antibody.  Before  absorption,  the  anti-R pneumococcus 
serum hemolyzed sheep cells in a  dilution of 1:800.  After absorption it failed 
TABLE  III 
The Protective Action in Mice of Anti-R Pneumococcus Sera against Pneuraococcus 
Type III and the Effect of Absorbing Suck Sera with C Carbohydrate and 
Guinea Pig Kidney 
Group 2  Group 3 
0.,5 ¢c.  Group I  0.5 cc.  anti-R  Group 4 
0.5 cc.  anti-R  rabbit  0.5 cc. 
normal  anti-R  rabbit  serum  Group 5 
rabbit  serum  absorbed  rabbit  Untreated 
serum  absorbed  with ~uiuea  serum 
intraperi-  with C  pig kldney  intraperi- 
toneally  intraperl-  intraperi-  toneal]y 
tone.ally  toneally 
S  D  S  D  S  D  S  D  S  D 
Experiment 1  9  1  2  8  nd  nd  1  9  nd  nd 
Experiment 2  5  5  0  11  7  3  4  7  1  3 
Totals ......  14  6  2  19  7  3  5  16  1  3 
Remarks 
Groups  1,  2,  4 
received  approx- 
imately 5,800 Pn 
intravenously 
Groups  1,  2,  3,  4 
received approxi- 
mately  3,40C 
Pn intravenously. 
Group 5 received 
approximately  34 
Pn intravenously 
Ali mice injected intravenously with 0.2 cc. of dilution of 6 hour broth culture 
of strain SV. 
In the case of each mouse that died a culture of the heart's blood revealed the 
presence of pneumococcus. 
to do so in a dilution of 1:5,--the lowest dilution tested.  0.5 cc. of normal rabbit 
serum was injected into a fourth series of mice.  24 hours later all the mice were 
injected intravenously with 0.2 cc. of a  10 -4 dilution of a  6 hour broth cultureof 
strain SV.  Intravenous inoculation was employed since it was found that little or 
no protection was demonstrable when the culture was injected into the peritoneum. 
The results of two experiments, in only one of which,  however, was the serum 
absorbed with guinea pig kidney employed, are summarized in Table III.  AI- 432  ~ITY  TO  PBFEITMOCOCCUS  TYPE  IH.  IV 
though the differences are not as sharp as one may obtain in protection tests with 
type specific sera and the intraperitoneal injection of the culture, they nevertheless 
seem sufficient to reveal a protective property in the anti-R serum, which is greater 
than that shown by normal rabbit serum.  The latter in Experiment 2 appears 
to have a  slight  action, since  the percentage of untreated mice dying with  a 
hundredfold-smaller  inoculum exceeds that of those injected with normal rabbit 
serum (of. group 5 in Table III).  Absorption  of the anti-R serum with C carbo- 
hydrate, whether the result of a single experiment is considered, or the combined 
figures, is dearly associated  with the removal of the protective property.  Addi- 
tional experiments of the same type not given here confirm this result.  Elimina- 
tion of the Forssman antibody apparently does not reduce the protection afforded 
by the R  serum.  Indeed, there is little reason to believe that it would do so, 
since the mouse tissues  contain the antigen and would presumably remove the 
antibody before it might influence the pneumococcus.  We included this control, 
however, to exclude any possible participation of the Forssman antibody in this 
non-type specific protection by anti-R serum. 
Similar experiments have been undertaken using strain CH.  With this organ- 
ism it was impossible to demonstrate any increase  in resistance  associated  with 
the R  serum.  We attribute this failure to the fact that the normal mouse pos- 
sesses a high degree of natural immunity against this strain when introduced in- 
travenously.  For testing the action of the R serum relatively enormous numbers 
of cocci must be introduced which in any case would probably overwhelm the 
majority of animals. 
In general, we fed justified in concluding that anti-R pneumococcus 
rabbit serum containing antibody reacting with the  C  carbohydrate 
wiU  protect certain mice against 100 or more g.L.D, of strain SV when 
administered  by the  intravenous route.  This protection disappears 
when the  anti-C  carbohydrate precipitin is removed by preliminary 
treatment with the homologous antigen,  and therefore appears to be 
due to the action of that antibody. 
An Attempt to Actively Immunize Mice with R Vaccine against Infection 
with Pneumococcus Type III 
Since antiserum produced in the rabbit in response to injection of R 
vaccine apparently conferred a  certain degree of protection upon the 
mouse  against  virulent  Pneumococcus  III,  provided  the  organisms 
were  intravenously injected,  experiments were  undertaken  with  the 
object of determining whether or not active immunization of the mouse 
was  possible  following  vaccination  with  suspensions  of  killed  R 
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Twelve mice received three courses of intraperitoneal injections of 0.1  cc. of a 
suspension of 16 hour culture of R organisms resuspended in 0.3 per cent formalin- 
ized saline.  Three injections on consecutive days were given in each course, fol- 
lowed by a  rest of 5 to 7 days.  To compare any resistance which might result 
from such vaccination with that obtained following injections of smooth Type III 
vaccine, the same number of animals were given the same course of immunization 
with a  suspension in 0.3 per cent formalinized saline of twice the number of SV 
organisms centrifuged from a  6 hour broth culture.  10 days following the last 
course of vaccine, the animals were divided in groups of six each and inoculated 
intravenously with 0.2 cc. of dilutions of a 6 hour broth culture of strain SV.  The 
results, together with those of unvaccinated controls, are recorded in Table IV. 
They obviously do not present definite evidence for the development of active 
immunity, following vaccination with the R  form.  The  survival of three mice 
out of the twelve injected with R  vaccine, and the death of all the nonvaccinated 
controls, although these received in some cases fewer pneumococci, are facts which 
TABLE  IV 
Active Immunization of Mice, Using R and S Vaccines 
Group 1 
Vaccinated with R 
pneumococcus 
N'o. pneumo- 
cocci  inocu- 
lated...  21,000  2,100 
Result  .........  S  D  S  D 
2  4  1  5 
Group 2 
Vaccinated with S 
Pneumococcus Type III 
21,000  2,100 
S  D  S  n 
4  2  5  1 
Group 3 
Non-vaccinated controls 
2,100  210 
s  D  S  D 
0  3  0  4 
suggest without proving that a  slight resistance occurred after treatment with R 
vaccine.  The number of survivors in the groups prepared with S vaccine is suffi- 
ciently large to indicate definite protection which, however, is not by any means 
absolute.  This fact, indicating as it does the difficulty with which active immuni- 
zation of any kind against Pneumococcus Type III is obtained in the mouse, may 
serve to explain the doubtful immunity following injection of R organisms which at 
best one could expect to be much less pronounced than that induced by the S 
vaccine.  It is possible that  more prolonged immunization with  the  R  variant 
might reveal more definite evidence fo  r the development of active immunity. 
An Attempt to Eliminate the Natural Immunity of the Mouse to Strain 
CH by Injection of the C Carbohydrate 
The  protection  conveyed to  mice  by  the  administration  of anti-R 
serum and the removal of the protective property upon the saturation 
of  the  serum  with  the  C  carbohydrate  furnish  a  certain  amount  of 434  IMMLrNITY  TO  PNEUMOCOCCUS  TYPE  III.  IV 
information  concerning the mechanism by which the rabbit virulent 
organisms may be resisted in the absence of the type specific antibody. 
We  lack,  however,  complete  data  concerning  the  humoral  factors 
which may participate in the removal by the normal  animal of either 
this strain or the less virulent  strain  CH, although  the depression of 
phagocytosis in normal cells and serum by the C carbohydrate points 
to  a  participation  of  the  corresponding  antibody.  Therefore,  the 
attempt  was made to reduce the  resistance  of the normal mouse to 
strain  CH inoculated intravenously by an antecedent injection of the 
C  carbohydrate with a  view to reducing or removing in  the  animal 
any natural  antibody which might react with it, since a  similar pro- 
cedure had  been  found effective in removing the immunity induced 
by previous vaccination  with Pneumococcus Type I  acetyl polysac- 
charide (Enders and Wu (8)). 
Twenty mice were injected intraperitoneally with 0.5 cc. of 1:500 dilution of 
the C carbohydrate  in physiological saline.  Another lot was injected with the 
same quantity of saline as controls.  3 hours afterwards, the group receiving C 
carbohydrate was divided into four lots of five mice each.  Each lot was injected 
with 0.2 cc, of broth dilutions of 6 hour cultures of strain CH, falling from 1 : 100 
to 1:100,000 by tenfold quantities.  The controls were divided into lots of four 
each and injected with dilutions from 1  : 10 to 1 : 100,000 of the same culture.  No 
significant differences were found in the number of deaths that occurred in lots 
receiving the same quantity of organisms, but one of which had been previously 
treated with the C carbohydrate. 
This failure to demonstrate any depression of the resistance of the 
normal  mouse to strain  CH by preliminary  injection of the  C  sub- 
stance may be attributed either to the nonparticipation  of the corre- 
sponding antibody in this protection, or to its incomplete removal by 
the  amount  of  C  carbohydrate  administered.  We  are  inclined  to 
regard the last hypothesis as more plausible. 
DISCUSSION 
Although  the  C  carbohydrate of the pneumococcus was isolated 6 
years ago,  little  study has  been  devoted to  its  possible r61e in  the 
mechanisms  of immunity.  It  is  known  that  this  material  forms  a 
precipitate  with  its homologous antibody in vitro,  and  that  its  dis- 
tribution  among  bacteria  is apparently  not limited  to  the  pneumo- J.  F.  ENDERS,  C.-J.  WU,  AND  M.  F.  SHAI~1~'ER  43~ 
coccus alone, since cross reactions have been obtained, for example, 
with antimeningococcus serum.  Furthermore, observations by Til- 
lett and Francis (9), and by Finland and Dowling (10) show that when 
the C  substance is injected intradermally into patients in the early 
stages of pneumonia an inflammatory reaction occurs.  Subsequent 
to the time of crisis,  the material fails to elicit this response.  These 
facts suggest that an antibody reacting with the C substance is present 
during the period of acute illness, but reveal nothing as to its function. 
Before the discovery of the C carbohydrate, it was demonstrated 
that  resistance  in  rabbits  against  virulent  Type  III  pneumococci 
developed following the injection of vaccines consisting of R organisms, 
or  those  of  heterologous smooth  types.  Such  resistance  could  be 
passively transferred to other rabbits with the blood or serum of those 
actively immunized.  Tillett (2) believed that this protection did not 
depend upon the presence of the antipneumococcus protein antibody, 
or indeed upon the presence of any antibody, since his experiments 
showed that, whereas pure nucleoprotein (at that time the only species 
antigen recognized), or solutions of pneumococci, produced high titres 
of this antibody, but exhibited no protective power, the injection of 
intact R pneumococci or the smooth organisms of a heterologous type 
resulted in the appearance of protective properties in the serum. 
The experiments described in this paper not only serve to suggest 
that the C carbohydrate and its corresponding antibody are involved 
in this non-type specific immunity against  the pneumococcus, but, 
also, in fulfillment of their immediate objective afford an understand- 
ing of at least one of the humoral factors concerned in the defense of 
the normal animal against the two strains of Pneumococcus Type III, 
which  are  our  particular  concern.  Specifically,  they  have  shown 
that the C carbohydrate obtained from cultures of a rough variant of 
Pneumococcus Type I may inhibit the opsonic properties of the normal 
serum of  man  and  the  rabbit,  which promote the phagocytosis of 
virulent  Type III pneumococcus.  Furthermore, it has been found 
that an antiserum prepared against the same R  variant of Pneumo- 
coccus Type I  has a definite, though limited, opsonizing effect upon 
the smooth Type III organisms, which is abolished in the presence of 
a  suitable quantity of the C carbohydrate.  It is to be emphasized 
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is effective in vitro  as an opsonin only against organisms possessing 
imperfect capsules.  Evidence that the antibody is active, not merely 
in the test tube, but also in the animal body is presented by experi- 
ments  in  which the  anti-P,  serum  injected  into  one  lot of  mice 
apparently  affords protection against a subsequent dose of the rabbit 
virulent Pneumococcus Type III provided these be inoculated by the 
intravenous route, while introduction of the same antiserum absorbed 
with the C carbohydrate fails to induce any increase in the resistance of 
the animals.  The results of attempts to actively immunize mice against 
this  strain  by  repeated injection of R  pneumococcus vaccine have 
proved inconclusive, but suggest that a  slight depression of suscep- 
tibility to infection occurs in some animals.  Injection of the C sub- 
stance into normal mice previous to intravenous infection with the 
rabbit avirulent strain failed to reduce the high resistance of the ani- 
mMs.  It  also  proved impossible by  preliminary  administration of 
the anti-R serum to increase the resistance of normal mice against CH. 
In spite of these failures, we believe that taken as a whole, the find- 
ings indicate that when the capsule of either strain has become slightly 
damaged, the anti-C antibody, which is present in normal animals in 
small amounts, may exert an opsonizing action which results in pha- 
gocytosis of the organisms, either by the leucocytes or the fixed tissue 
cells, as has been shown to occur (cf. Paper III).  Since alterations in 
the capsule of the rabbit avirulent strain have been demonstrated to 
take place more rapidly, and in a given time are more extensive, it is 
most probable that smaller quantities of this antibody are more effec- 
tive against this strain than against the rabbit virulent strain, which 
maintains a large capsule for many hours.  It is, however, also clear 
that  in  vitro  capsular  degradation may proceed to  such an  extent 
that  sensitization  with  the  anti-C  antibody  is  not  necessary  as  a 
preliminary step in the process of phagocytosis.  During the natural 
course of infection this state is probably seldom attained, since be- 
fore it is reached, opsonization by  the  anti-C  antibody would have 
taken place with the resulting elimination of the organism. 
If these findings prove to be correct and are found to have a more 
extensive application, one might possibly regard the anti-C carbohy- 
drate  antibody as  an important factor in the natural immunity of 
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but with other organisms such as the meningococcus which possess, 
if not an identical, at least a  similar antigenic constituent.  Indeed, 
it does not appear illogical to think that this antibody may function 
successfully in protecting from infection those persons such as prac- 
tically all infants, many young children and some adults, who have 
in their serum no naturally occurring antibody corresponding to the 
type specific antigen. 
CONCLUSIONS 
1.  The phagocytosis of rabbit virulent and rabbit avirulent strains 
of Pneumococcus  Type III by the cells and serum of both man and the 
normal rabbit is decreased by the previous addition of the C  carbo- 
hydrate of Tillett, Goebel and Avery. 
2.  The addition of anti-R pneumococcus serum to normal rabbit 
serum and cells results in increased phagocytosis of these strains, which 
is removed by the C carbohydrate. 
3.  Anti-R pneumococcus rabbit  serum will protect  mice  against 
100  or more ~.L.D.  of the rabbit  virulent strain  of  Pneumococcus 
Type III,  provided the organisms are injected by  the intravenous 
route. 
4.  Absorption of anti-R pneumococcus rabbit  serum with the  C 
carbohydrate removes the mouse protective property. 
5.  The application of these findings to the mechanism responsible 
for the removal of the rabbit virulent and avirulent strains from the 
circulating blood of the normal animal is discussed. 
SUMMARY  AND  GENERAL  CONCLUSIONS 
Since there is no evidence for the occurrence of type specific anti- 
body in the normal rabbit and since, as we have shown, the Pneumo- 
coccus Type III whether avirulent or virulent is not removed from 
the blood stream or destroyed when the capsule is intact, the follow- 
ing factors which have been revealed in the course of our work appear 
to represent certain essential components, if not the complete mech- 
anism, upon which the natural immunity of the rabbit  against this 
organism depends.  (a)  The elevation of the body temperature after 
intravenous infection to  41°C.  or thereabouts and  its  maintenance 
for varying periods.  (b) The ability of the phagocytic cells, both fixed 438  IMMUNITY TO  PNEUMOCOCCUS TYPE III.  IV 
and mobile, to attack any cocci which have become vulnerable through 
the deterioration of capsular integrity.  (c) The adjuvant effect of an 
antibody, reacting with the somatic C carbohydrate, which enhances 
the phagocytosis of such organisms as no longer possess a completely 
intact envelope. 
Conversely, the varying degrees of virulence for rabbits observed 
among Pneumococcus  Type III strains are based upon:  (a) differences 
in the ability of the organisms to multiply at the elevated temperatures 
encountered in the infected host.  Strains markedly susceptible to 
the harmful influence of this factor Jail to induce a generalized fatal 
infection.  Not  all  "thermo-resistant"  strains  are  highly  virulent, 
however, and these may contrast sharply with regard to  (b)  size of 
the capsule and the ease with which it is impaired or completely lost. 
The  capsules must be maintained intact  for a  sufficient time until 
multiplication of the organisms can proceed to such a degree that death 
of the host results.  Avirulent strains even when capable of growth 
at 41°C. appear to be unable to satisfy this requirement. 
The  differences  in  virulence  of  various  strains  apparently  con- 
ditioned by these {actors are not limited solely to the case of the rabbit, 
since for at least two strains similar differences in virulence have been 
shown to exist when the intravenous route of infection is employed in 
mice. 
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